Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 260-265

  Herr, Wolfgang ^a   Protzer, Ulla ^a   Lohse, Ansgar W ^a   Gerken, Guido ^a   Büschenfelde, Karl Hermann Meyer Zum ^a   Wölfel, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA A3 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; IMMUNOGENICITY; IMMUNOREACTIVITY; INFECTION RISK; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031845237     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517449     Document Type: Article

References (16)

1. Safrit JT, Koup RA. The immunology of primary HIV infection: which immune responses control HIV infection? Curr Opin Immunol 1995;7:456-61.
2. Nixon DF, McMichael AJ. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 1991;5:1049-59.
3. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-9.
4. Cheynier R, Langlade-Demoyen P, Marescot MR, et al. Cytotoxic T lymphocyte response in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992;22:2211-7.
5. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1995;1:59-64.
6. Pinto LA, Sullivan J, Berzofsky JA, et al. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995;96:867-76.
7. + T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods 1996;191:131-42.
8. + T lymphocytes producing rumor necrosis factor α spots in response to peptide antigens. J Immunol Methods 1997;203:141-52.
9. Sanchez-Pescador R, Power MD, Barr PJ, et al. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 1985;227:484-92.
10. Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med 1994;180:1283-93.
11. van der Burg SH, Klein MR, van de Velde CJ, Kast WM, Miedema F, Melief CJ. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 1995;9:121-7.
12. + T cells in the central region of the HIV-1 nef protein. J Immunol 1991;146:1560-5.
13. + cytotoxic T lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. Proc Natl Acad Sci USA 1991;88:10277-81.
14. Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. J Virol 1994;68:3145-53.
15. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a. human melanoma. Science 1995;269:1281-4.
16. Bednarek MA, Sauma SY, Gammon MC, et al. The minimum peptide epitope from influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol 1991;147:4047-53.